{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:32:35Z","timestamp":1790771555678,"version":"4.1.0"},"reference-count":33,"publisher":"Japanese Association for Laboratory Animal Science","issue":"3","funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K08860"],"award-info":[{"award-number":["20K08860"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["21K08579"],"award-info":[{"award-number":["21K08579"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1538\/expanim.24-0154","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T17:11:36Z","timestamp":1737997896000},"page":"319-327","source":"Crossref","is-referenced-by-count":9,"title":["The usefulness of HbA1c measurement in diabetic mouse models using various devices"],"prefix":"10.1538","volume":"74","author":[{"given":"Koya","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Division of Medical Chemistry, Department of Metabolism and Diseases, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo 654-0142, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Medical Chemistry, Department of Metabolism and Diseases, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo 654-0142, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Kido","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kimura-Koyanagi","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kido","sequence":"additional","affiliation":[{"name":"Division of Medical Chemistry, Department of Metabolism and Diseases, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-ku, Kobe, Hyogo 654-0142, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichiro","family":"Asahara","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","unstructured":"1. International Diabetes Federation. IDF Diabetes Atlas 10th edition. Brussels: International Diabetes Federation;  2021. https:\/\/diabetesatlas.org\/."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese clinical practice guideline for diabetes 2019. J Diabetes Investig.  2020;  11: 1020\u20131076.","DOI":"10.1111\/jdi.13306"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.  1993;  329: 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.  1998;  352: 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mayer TK, Freedman ZR. Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility. Clin Chim Acta.  1983;  127: 147\u2013184.","DOI":"10.1016\/S0009-8981(83)80002-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights.  2016;  11: 95\u2013104.","DOI":"10.4137\/BMI.S38440"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Koenig RJ, Araujo DC, Cerami A. Increased hemoglobin AIc in diabetic mice. Diabetes.  1976;  25: 1\u20135.","DOI":"10.2337\/diabetes.25.1.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koenig RJ, Cerami A. Synthesis of hemoglobin AIc in normal and diabetic mice: potential model of basement membrane thickening. Proc Natl Acad Sci USA.  1975;  72: 3687\u20133691.","DOI":"10.1073\/pnas.72.9.3687"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dan K, Fujita H, Seto Y, Kato R. Relation between stable glycated hemoglobin A1C and plasma glucose levels in diabetes-model mice. Exp Anim.  1997;  46: 135\u2013140.","DOI":"10.1538\/expanim.46.135"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dubuc PU, Scott BK, Peterson CM. Sex differences in glycated hemoglobin in diabetic and non-diabetic C57BL\/6 mice. Diabetes Res Clin Pract.  1993;  21: 95\u2013101.","DOI":"10.1016\/0168-8227(93)90055-A"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fujii E, Nomoto T. Changes in glycosylated hemoglobin in short- and semi long-term streptozotocin-diabetic mice and rats. Jpn J Pharmacol.  1984;  34: 113\u2013115.","DOI":"10.1016\/S0021-5198(19)52379-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Weykamp C, John WG, Mosca A. A review of the challenge in measuring hemoglobin A1c. J Diabetes Sci Technol.  2009;  3: 439\u2013445.","DOI":"10.1177\/193229680900300306"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med.  2013;  33: 393\u2013400.","DOI":"10.3343\/alm.2013.33.6.393"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lenters-Westra E, English E. Are hemoglobin A<sub>1c<\/sub> point-of-care analyzers fit for purpose? The story continues. Clin Chem Lab Med.  2020;  59: 765\u2013774.","DOI":"10.1515\/cclm-2020-1308"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med.  2004;  10: 168\u2013174.","DOI":"10.1038\/nm980"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Urrechaga E. Analytical evaluation of the ADAMS<sup>TM<\/sup> A1c HA8180T analyzer for the measurement of HbA1c. J Clin Lab Anal.  2018;  32: e22155.","DOI":"10.1002\/jcla.22155"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yonehara S, Inamura N, Fukuda M, Sugiyama K. Use of fructosyl peptide oxidase for HbA1c assay. J Diabetes Sci Technol.  2015;  9: 200\u2013205.","DOI":"10.1177\/1932296815569573"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Degandt S, Coens R, Cauwelier B, Devos H, Langlois M, Emmerechts J. Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis. J Clin Lab Anal.  2018;  32: e22224.","DOI":"10.1002\/jcla.22224"},{"key":"19","unstructured":"19. Nitin S. HbA1c and factors other than diabetes mellitus affecting it. Singapore Med J.  2010;  51: 616\u2013622."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol.  2001;  21: 15\u201323.","DOI":"10.1002\/jat.727"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Boucher BJ, Burrin JM, Gould BJ, John PN, Lewis G, Owens C, et al. A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom. Diabetologia.  1983;  24: 265\u2013271.","DOI":"10.1007\/BF00282711"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, et al. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science.  2016;  351: 285\u2013289.","DOI":"10.1126\/science.aad3312"},{"key":"23","unstructured":"23. John WG, Mosca A, Weykamp C, Goodall I. HbA1c standardisation: history, science and politics. Clin Biochem Rev.  2007;  28: 163\u2013168."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Higgins T. HbA(1c)--an analyte of increasing importance. Clin Biochem.  2012;  45: 1038\u20131045.","DOI":"10.1016\/j.clinbiochem.2012.06.006"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Van Putten LM. The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo. Blood.  1958;  13: 789\u2013794.","DOI":"10.1182\/blood.V13.8.789.789"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Popp RA, Popp DM, Johnson FM, Skow LC, Lewis SE. Hematology of a murine beta-thalassemia: a longitudinal study. Ann N Y Acad Sci.  1985;  445: 432\u2013444.","DOI":"10.1111\/j.1749-6632.1985.tb17213.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kanno A, Asahara SI, Kawamura M, Furubayashi A, Tsuchiya S, Suzuki E, et al. Early administration of dapagliflozin preserves pancreatic \u03b2-cell mass through a legacy effect in a mouse model of type 2 diabetes. J Diabetes Investig.  2019;  10: 577\u2013590.","DOI":"10.1111\/jdi.12945"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kanai Y, Lee WS, You G, Brown D, Hediger MA. The human kidney low affinity Na+\/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest.  1994;  93: 397\u2013404.","DOI":"10.1172\/JCI116972"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T, et al. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet.  2006;  38: 589\u2013593.","DOI":"10.1038\/ng1774"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Koyanagi M, Asahara S, Matsuda T, Hashimoto N, Shigeyama Y, Shibutani Y, et al. Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1. PLoS One.  2011;  6: e23238.","DOI":"10.1371\/journal.pone.0023238"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Asahara S, Etoh H, Inoue H, Teruyama K, Shibutani Y, Ihara Y, et al. Paternal allelic mutation at the Kcnq1 locus reduces pancreatic \u03b2-cell mass by epigenetic modification of Cdkn1c. Proc Natl Acad Sci USA.  2015;  112: 8332\u20138337.","DOI":"10.1073\/pnas.1422104112"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Asahara SI, Inoue H, Kido Y. Regulation of pancreatic \u03b2-cell mass by gene-environment interaction. Diabetes Metab J.  2022;  46: 38\u201348.","DOI":"10.4093\/dmj.2021.0045"},{"key":"33","doi-asserted-by":"crossref","first-page":"e160555","DOI":"10.1172\/jci.insight.160555","volume":"7","year":"2022","unstructured":"33. Osonoi S, Mizukami H, Takeuchi Y, Sugawa H, Ogasawara S, Takaku S, et al. RAGE activation in macrophages and development of experimental diabetic polyneuropathy. JCI Insight.  2022;  7: e160555.","journal-title":"JCI Insight","ISSN":"https:\/\/id.crossref.org\/issn\/2379-3708","issn-type":"print"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/3\/74_24-0154\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T03:50:11Z","timestamp":1752292211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/3\/74_24-0154\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.24-0154","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0154"}}